Pan-cancer T cell atlas reveals new details of tumor microenvironment
A new study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, provides a deeper understanding of the vast diversity of T cell states as well as their relationships and roles within the complex tumor microenvironment, bringing a fresh perspective to understanding immunotherapy efficacy in cancer.
Recent studies have shown that the phenotypic states of T cells, as well as...
MD Anderson Research Highlights: ASCO 2023 Special Edition
ABSTRACTS: 398868, 425082, 6546, 3501, 6008, 9502, 9011, 9008
CHICAGO ― The University of Texas MD Anderson Cancer Center’s Research...
ASCO: Luspatercept enables majority of patients with MDS to end reliance on blood transfusions
ABSTRACT: 7003
Treatment with luspatercept improved red blood cell counts and erythroid responses compared to treatment with epoetin...
MD Anderson Research Highlights for May 24, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Recent developments include a new treatment option for relapsed/refractory mantle cell lymphoma, a...
MD Anderson awarded over $5.7 million from Break Through Cancer to support AML research
The University of Texas MD Anderson Cancer Center was awarded more than $5.7 million in grants from Break Through Cancer to support collaborative...
Combined delivery of engineered virus with immunotherapy is safe and improves outcomes in subset of patients with glioblastoma
Intratumoral delivery of an engineered oncolytic virus (DNX-2401) targeting glioblastoma (GBM) cells combined with subsequent immunotherapy...
MD Anderson Research Highlights for May 10, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
Allison Institute announces appointment of inaugural members
The James P. Allison Institute at The University of Texas MD Anderson Cancer Center today announced the appointment of its first members,...
MD Anderson researchers Helen Piwnica-Worms and Richard Wood elected to National Academy of Sciences
Two researchers from The University of Texas MD Anderson Cancer Center have been elected to the prestigious National Academy of...